Lactoferricin Peptides Also Lower Blood Pressure by Blocking ACE — Anti-Infection AND Anti-Hypertension

Lactoferricin-derived peptides showed ACE-inhibitory activity, reducing vasoconstriction — adding blood pressure-lowering potential to lactoferricin's known antimicrobial and anticancer properties.

Centeno, José M et al.·Journal of agricultural and food chemistry·2006·Preliminary Evidencein-vitro
RPEP-01123In VitroPreliminary Evidence2006RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in-vitro
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Lactoferricin-related peptides inhibited ACE-dependent vasoconstriction, adding blood pressure-lowering activity to the antimicrobial, anticancer, and immunomodulatory profile of this milk-derived peptide family.

Key Numbers

How They Did This

in-vitro study on antimicrobial-peptides, cardiovascular.

Why This Research Matters

Relevant for antimicrobial-peptides, cardiovascular, bioactive-food-peptides.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding Lactoferricin-related peptides inhibited ACE-dependent vasoconstriction, adding blood pressure-lowering activity to the antimicrobial, anticancer, and
Evidence Grade:
preliminary evidence.
Study Age:
Published in 2006.
Original Title:
Lactoferricin-related peptides with inhibitory effects on ACE-dependent vasoconstriction.
Published In:
Journal of agricultural and food chemistry, 54(15), 5323-9 (2006)
Database ID:
RPEP-01123

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What was studied?

Lactoferricin Peptides Also Lower Blood Pressure by Blocking ACE — Anti-Infection AND Anti-Hypertension

What was found?

Lactoferricin-derived peptides showed ACE-inhibitory activity, reducing vasoconstriction — adding blood pressure-lowering potential to lactoferricin's known antimicrobial and anticancer properties.

Read More on RethinkPeptides

Cite This Study

RPEP-01123·https://rethinkpeptides.com/research/RPEP-01123

APA

Centeno, José M; Burguete, María C; Castelló-Ruiz, María; Enrique, María; Vallés, Salvador; Salom, Juan B; Torregrosa, Germán; Marcos, José F; Alborch, Enrique; Manzanares, Paloma. (2006). Lactoferricin-related peptides with inhibitory effects on ACE-dependent vasoconstriction.. Journal of agricultural and food chemistry, 54(15), 5323-9.

MLA

Centeno, José M, et al. "Lactoferricin-related peptides with inhibitory effects on ACE-dependent vasoconstriction.." Journal of agricultural and food chemistry, 2006.

RethinkPeptides

RethinkPeptides Research Database. "Lactoferricin-related peptides with inhibitory effects on AC..." RPEP-01123. Retrieved from https://rethinkpeptides.com/research/centeno-2006-lactoferricinrelated-peptides-with-inhibitory

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.